Skip to content

Released Aug 13, 2014, after the close

10-Q filed Aug 13, 2014, 44 days after period end · 0001144204-14-049314

Q2 2014 · 10-Q
Revenue—
Net Income-$6.97MN/M vs Q2 2013N/M vs Q1 2014
EPS Diluted-$0.55N/M vs Q2 2013N/M vs Q1 2014
Operating Income-$7,009,562N/M
Operating Cash Flowderived-$7,646,300N/M
Free Cash Flowderived-$7,646,300N/M

What the release said

The release

Same quarter

MetricQ2 2014Q2 2013Q2 2012
Net Income-$6.97M-$1.37M-$61.23K
EPS Diluted-$0.55-$0.31—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR